Radiology reporting of adrenal incidentalomas - Who requires further testing?

10Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Adrenal incidentalomas (AIs) are common and guidelines recommend testing to exclude functioning lesions and malignancy. Their increasing prevalence results in several investigations that are usually conducted in the endocrinology clinic. In 2011, we audited the prevalence and management of AIs identified on computed tomography (CT) imaging of abdomen over 1 calendar month. Consequently, a decision pathway for adrenal lesions was introduced in the radiology department of the Royal Free London Hospital. One year later, we re-audited the local practice. In total, 690 CT scans were reviewed in 2011 compared with 1,264 in 2012. In 2011, 17 (2.46%) patients with AIs were identified, and 26 (2.01%) in 2012. Of those, 1.01% in 2011 and 0.95% in 2012 had newly identified AIs. Only a few patients had been tested to exclude a functional lesion and there was inconsistent terminology in reporting adrenal lesions. Therefore, we support comprehensive reporting of AIs and a selective testing strategy. © Royal College of Physicians 2014. All rights reserved.

Cite

CITATION STYLE

APA

Paterson, F., Theodoraki, A., Amajuoyi, A., Bouloux, P. M., Maclachlan, J., & Khoo, B. (2014). Radiology reporting of adrenal incidentalomas - Who requires further testing? Clinical Medicine, Journal of the Royal College of Physicians of London, 14(1), 16–21. https://doi.org/10.7861/clinmedicine.14-1-16

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free